title: Paraoxonases as protective agents against N-acyl homoserine lactone - producing pathogenic microorganisms.
abstract: Paraoxonases are a group of enzymes with a high "substrate-promiscuity", being able to act on many structurally different compounds. To date, there is no consensus regarding the physiological substrate(s) of these enzymes. Recent data suggest that the N-acyl homoserine lactones (AHLs) produced by different Gram-negative bacteria, including the opportunistic Pseudomonas aeruginosa, could be such substrates. Due to the ability of paraoxonases to hydrolyze AHLs, they represent an alternative mechanism of protection against pathogen microorganisms, interfering with the quorum sensing systems that allow these bacteria to respond in a coordinate manner to different changes in the extracellular environment. This mini-review presents some novel aspects regarding the relationship between paraoxonases and the aforementioned compounds, highlighting the potential role of these enzymes as a component of the humoral innate defence system.
authors.forename: Bogdan Nicolae
authors.initials: BN
authors.lastname: Manolescu
keywords: acylhomoserine lactone (AHLs); paraoxonases; quorum sensing; sepsis
references.citation: Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):542-7
references.pmid: 11304470
references.citation: Nat Genet. 1996 Nov;14(3):334-6
references.pmid: 8896566
references.citation: BMC Clin Pathol. 2008 Oct 28;8:10
references.pmid: 18954471
references.citation: Adv Exp Med Biol. 2010;660:183-93
references.pmid: 20221881
references.citation: Biochem Pharmacol. 2003 Sep 15;66(6):887-96
references.pmid: 12963475
references.citation: Genomics. 1996 May 1;33(3):498-507
references.pmid: 8661009
references.citation: FEBS Lett. 2005 Jul 4;579(17):3713-7
references.pmid: 15963993
references.citation: Trends Microbiol. 2006 Feb;14(2):55-8
references.pmid: 16406629
references.citation: J Biol Chem. 2000 Feb 11;275(6):3957-62
references.pmid: 10660550
references.citation: Biochemistry. 2005 Apr 26;44(16):6371-82
references.pmid: 15835926
references.citation: Crit Rev Clin Lab Sci. 2009;46(2):83-106
references.pmid: 19255916
references.citation: J Clin Microbiol. 2007 Sep;45(9):2819-28
references.pmid: 17609322
references.citation: Free Radic Biol Med. 2011 Jan 1;50(1):102-9
references.pmid: 20850524
references.citation: J Biol Chem. 1989 Dec 25;264(36):21670-6
references.pmid: 2600086
references.citation: Philos Trans R Soc Lond B Biol Sci. 2007 Jul 29;362(1483):1201-11
references.pmid: 17360274
references.citation: Clin Exp Med. 2010 Mar;10(1):21-5
references.pmid: 19760042
references.citation: Am J Physiol Lung Cell Mol Physiol. 2007 Apr;292(4):L852-60
references.pmid: 17122353
references.citation: J Clin Invest. 2008 Sep;118(9):3123-31
references.pmid: 18704198
references.citation: Biochem J. 1953 Jan;53(1):110-7
references.pmid: 13032041
references.citation: Drug Metab Dispos. 2000 Nov;28(11):1335-42
references.pmid: 11038162
references.citation: Biochem J. 1953 Jan;53(1):117-24
references.pmid: 13032042
references.citation: Biochem Pharmacol. 1989 Feb 1;38(3):385-90
references.pmid: 2917004
references.citation: Microbes Infect. 2000 Jul;2(9):1051-60
references.pmid: 10967285
references.citation: J Lipid Res. 2005 Jun;46(6):1239-47
references.pmid: 15772423
references.citation: Burns. 2004 Nov;30(7):660-4
references.pmid: 15475138
references.citation: Anal Biochem. 2007 Feb 15;361(2):226-35
references.pmid: 17207763
references.citation: Infect Immun. 2008 Jun;76(6):2512-9
references.pmid: 18347034
references.citation: FEMS Microbiol Lett. 2005 Dec 1;253(1):29-37
references.pmid: 16260097
references.citation: Gene. 1998 Jun 15;213(1-2):149-57
references.pmid: 9714608
references.citation: Cell. 2006 Apr 21;125(2):237-46
references.pmid: 16630813
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2004 Jan;369(1):78-88
references.pmid: 14579013